Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 2
2021 5
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration.
Ikeda S, Sekine A, Baba T, Kato T, Katano T, Tabata E, Shintani R, Yamakawa H, Oda T, Okuda R, Kitamura H, Iwasawa T, Takemura T, Ogura T. Ikeda S, et al. Among authors: sekine a. Medicine (Baltimore). 2022 Jun 3;101(22):e29232. doi: 10.1097/MD.0000000000029232. Medicine (Baltimore). 2022. PMID: 35665728 Free PMC article. Clinical Trial.
Low starting-dosage of nintedanib for the reduction of early termination.
Ikeda S, Sekine A, Baba T, Katano T, Tabata E, Shintani R, Yamakawa H, Niwa T, Oda T, Okuda R, Kitamura H, Ogura T. Ikeda S, et al. Among authors: sekine a. Respir Investig. 2019 May;57(3):282-285. doi: 10.1016/j.resinv.2018.12.010. Epub 2019 Feb 13. Respir Investig. 2019. PMID: 30772264 No abstract available.
Clinical characteristics of Japanese patients with moderate to severe COVID-19.
Otoshi R, Hagiwara E, Kitayama T, Yamaya T, Higa K, Murohashi K, Sato Y, Tabata E, Shintani R, Okabayashi H, Ikeda S, Niwa T, Nakazawa A, Oda T, Okuda R, Sekine A, Kitamura H, Baba T, Komatsu S, Ogura T. Otoshi R, et al. Among authors: sekine a. J Infect Chemother. 2021 Jun;27(6):895-901. doi: 10.1016/j.jiac.2021.02.028. Epub 2021 Mar 4. J Infect Chemother. 2021. PMID: 33727024 Free PMC article.
Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis.
Sekine A, Hagiwara E, Iwasawa T, Otoshi R, Erina T, Shintani R, Okabayashi H, Ikeda S, Oda T, Okuda R, Kitamura H, Baba T, Komatsu S, Ogura T. Sekine A, et al. Respir Investig. 2021 Nov;59(6):837-844. doi: 10.1016/j.resinv.2021.05.010. Epub 2021 Jun 23. Respir Investig. 2021. PMID: 34172419
Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019.
Yamaya T, Hagiwara E, Baba T, Kitayama T, Murohashi K, Higa K, Sato Y, Otoshi R, Tabata E, Shintani R, Okabayashi H, Ikeda S, Niwa T, Nakazawa A, Oda T, Okuda R, Sekine A, Kitamura H, Komatsu S, Ogura T. Yamaya T, et al. Among authors: sekine a. Respir Investig. 2021 Sep;59(5):596-601. doi: 10.1016/j.resinv.2021.04.002. Epub 2021 Apr 27. Respir Investig. 2021. PMID: 33965361 Free PMC article.
Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases.
Murohashi K, Hagiwara E, Kitayama T, Yamaya T, Higa K, Sato Y, Otoshi R, Shintani R, Okabayashi H, Ikeda S, Niwa T, Nakazawa A, Oda T, Okuda R, Sekine A, Kitamura H, Baba T, Komatsu S, Iwasawa T, Kaneko T, Ogura T. Murohashi K, et al. Among authors: sekine a. Respir Investig. 2020 Nov;58(6):430-434. doi: 10.1016/j.resinv.2020.08.001. Epub 2020 Aug 28. Respir Investig. 2020. PMID: 32893160 Free PMC article.
12 results